| 26.95 Data as of May 17 | +0.04 / +0.15%Today’s Change | 26.26 Today|||52-Week Range 38.60 | -1.96% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.6B |
Company Description
Mesoblast Ltd. develops biological products for the broad field of regenerative medicine. Its products target cardiovascular conditions, diabetes, inflammatory conditions of lungs and joints, eye diseases, bone marrow cancers, bone fractures, cartilage degeneration and musculoskeletal conditions. The company operates through two segments: Orthopaedic, and Cardiovascular & non-orthopaedic. Mesoblast was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
Employees

Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Silviu Itescu, MBBS | Chief Executive Officer & Executive Director |
| Paul Rennie | Chief Operating Officer |
| Jennifer Pilcher | Chief Financial Officer & Secretary |
| Donna L. Skerrett, MD | Chief Medical Officer |
| Suzanne Lipe, PhD | Vice President-Operations |